Concepedia

Author

Ian Bathurst

Medicines for Malaria Venture

Also Known As

Bathurst, Ian, I Bathurst, I C Bathurst, I. Bathurst, I.C. Bathurst, IAN C. BATHURST, Ian Bathurst, Ian C Bathurst, Ian C. BATHURST, Ian C. Bathurst

83

Publications

4.2K

Citations

28

H-Index

71

Concepts

All Affiliations

Medicines for Malaria VentureChristchurch HospitalMonash UniversityUniversity of California, San FranciscoGlaxoSmithKline (Spain)
IB

About

Ian Bathurst is an author at Medicines for Malaria Venture specializing in medicine, immunology, and malaria.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

28

2.3K

2

Natural Sciences

10

10

578

3

Biochemistry

7

7

536

4

Allergy

2

2

28

5

Public Health

1

1

11

Ian Bathurst

×

53

Publications

4K

Citations

28

H-Index

YearCitations

Chemical genetics of Plasmodium falciparum

W. Armand Guiguemde, Anang A. Shelat, David C. Bouck,

Nature

2010

565

Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

Susan A. Charman, Sarah Arbe‐Barnes, Ian Bathurst,

Proceedings of the National Academy of Sciences

2011

374

Quinolone-3-Diarylethers: A New Class of Antimalarial Drug

Aaron Nilsen, Alexis N. LaCrue, Karen L. White,

Science Translational Medicine

2013

296

Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent<i>Plasmodium falciparum</i>Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential

José M. Coterón, María Marco, Jorge Esquivias,

Journal of Medicinal Chemistry

2011

280

Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.

P J Barr, Kerry Green, Helen L. Gibson,

The Journal of Experimental Medicine

1991

224

Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from  <i>Xenopus</i>  oocytes

Zhong Guo, Károly Liliom, David J. Fischer,

Proceedings of the National Academy of Sciences

1996

175

Lead Optimization of Aryl and Aralkyl Amine-Based Triazolopyrimidine Inhibitors of<i>Plasmodium falciparum</i>Dihydroorotate Dehydrogenase with Antimalarial Activity in Mice

Ramesh Gujjar, Farah El Mazouni, Karen L. White,

Journal of Medicinal Chemistry

2011

165

A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes

Íñigo Angulo‐Barturen, Marı́a Belén Jiménez-Dı́az, Teresa Mulet,

PLoS ONE

2008

161

Discovery, Synthesis, and Optimization of Antimalarial 4(1<i>H</i>)-Quinolone-3-Diarylethers

Aaron Nilsen, Galen P. Miley, Isaac Forquer,

Journal of Medicinal Chemistry

2014

120

Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 “- (4”-amino-1“,2”-oxathiole-2“,2”-dioxide)thymine (TSAO-T).

Jan Balzarini, María‐Jesús Pérez‐Pérez, Ana San‐Félix,

Journal of Biological Chemistry

1992

119

Page 1